Jiro Toyonaga

463 total citations
14 papers, 383 citations indexed

About

Jiro Toyonaga is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jiro Toyonaga has authored 14 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in Jiro Toyonaga's work include Dialysis and Renal Disease Management (4 papers), Hormonal Regulation and Hypertension (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Jiro Toyonaga is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Hormonal Regulation and Hypertension (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Jiro Toyonaga collaborates with scholars based in Japan and Greece. Jiro Toyonaga's co-authors include Kazuhiko Tsuruya, Kiichiro Fujisaki, Masatomo Taniguchi, Masanori Tokumoto, Takanari Kitazono, Mitsuo Iida, Shunsuke Yamada, Takaichi Suehiro, Hideko Noguchi and Mitsuo Iida and has published in prestigious journals such as SHILAP Revista de lepidopterología, Endocrinology and Kidney International.

In The Last Decade

Jiro Toyonaga

14 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Toyonaga Japan 8 175 94 87 54 51 14 383
Ronald St-Louis United States 8 115 0.7× 41 0.4× 87 1.0× 44 0.8× 52 1.0× 13 341
S. Cerci Italy 13 103 0.6× 124 1.3× 80 0.9× 59 1.1× 93 1.8× 30 433
Ricardo Kohan Israel 7 161 0.9× 39 0.4× 72 0.8× 42 0.8× 56 1.1× 13 339
Trevor H. Thomas United Kingdom 14 113 0.6× 113 1.2× 198 2.3× 120 2.2× 55 1.1× 29 539
Yihung Huang United States 14 257 1.5× 89 0.9× 242 2.8× 98 1.8× 86 1.7× 21 661
Kumiko Kaifu Japan 12 81 0.5× 194 2.1× 88 1.0× 33 0.6× 86 1.7× 15 426
Wararat Kittikulsuth United States 13 76 0.4× 147 1.6× 184 2.1× 54 1.0× 61 1.2× 25 465
A.S. Reddi United States 12 110 0.6× 137 1.5× 114 1.3× 30 0.6× 80 1.6× 43 524
Jeremy J. Bending United Kingdom 7 163 0.9× 241 2.6× 94 1.1× 57 1.1× 84 1.6× 10 487
Belgi̇n Efe Türkiye 9 59 0.3× 156 1.7× 70 0.8× 18 0.3× 52 1.0× 21 390

Countries citing papers authored by Jiro Toyonaga

Since Specialization
Citations

This map shows the geographic impact of Jiro Toyonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Toyonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Toyonaga more than expected).

Fields of papers citing papers by Jiro Toyonaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Toyonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Toyonaga. The network helps show where Jiro Toyonaga may publish in the future.

Co-authorship network of co-authors of Jiro Toyonaga

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Toyonaga. A scholar is included among the top collaborators of Jiro Toyonaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Toyonaga. Jiro Toyonaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Yamada, Shunsuke, Masanori Tokumoto, Masatomo Taniguchi, et al.. (2015). Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism. Therapeutic Apheresis and Dialysis. 19(4). 367–377. 17 indexed citations
3.
Hara, Takashi, et al.. (2015). Factors Contributing to Erythropoietin Hyporesponsiveness in Patients on Long-Term Continuous Ambulatory Peritoneal Dialysis: A Cross-Sectional Study. SHILAP Revista de lepidopterología. 5(3). 79–86. 6 indexed citations
4.
Suehiro, Takaichi, Kazuhiko Tsuruya, Hirofumi Ikeda, et al.. (2015). Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats. Endocrinology. 156(7). 2657–2666. 7 indexed citations
5.
Fujisaki, Kiichiro, Kazuhiko Tsuruya, Mayumi Yamato, et al.. (2013). Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: neuroprotective effect of tempol. Nephrology Dialysis Transplantation. 29(3). 529–538. 58 indexed citations
6.
Toyonaga, Jiro, Kazuhiko Tsuruya, Hirotaka Ikeda, et al.. (2011). Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Nephrology Dialysis Transplantation. 26(8). 2475–2484. 80 indexed citations
7.
Yamada, Shunsuke, et al.. (2011). Kienboeck's Disease: Unusual Cause of Acute Onset Wrist Pain in a Dialysis Patient. Internal Medicine. 50(5). 467–469. 2 indexed citations
8.
Yamada, Shunsuke, Masatomo Taniguchi, Masanori Tokumoto, et al.. (2011). The antioxidant tempol ameliorates arterial medial calcification in uremic rats: Important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. Journal of Bone and Mineral Research. 27(2). 474–485. 112 indexed citations
9.
Toyonaga, Jiro, Kohsuke Masutani, Kazuhiko Tsuruya, et al.. (2009). Severe anasarca due to beriberi heart disease and diabetic nephropathy. Clinical and Experimental Nephrology. 13(5). 518–521. 2 indexed citations
10.
Toyonaga, Jiro, Kazuhiko Tsuruya, Kohsuke Masutani, et al.. (2009). Hemorrhagic Shock and Obstructive Uropathy Due to a Large Rectus Sheath Hematoma in a Patient on Anticoagulant Therapy. Internal Medicine. 48(24). 2119–2122. 12 indexed citations
11.
Masutani, Kohsuke, Kiichiro Fujisaki, Jiro Toyonaga, et al.. (2008). Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib. Clinical and Experimental Nephrology. 12(5). 398–402. 26 indexed citations
12.
Ikeda, Hirofumi, Kazuhiko Tsuruya, Jiro Toyonaga, et al.. (2008). Spironolactone suppresses inflammation and prevents L-NAME–induced renal injury in rats. Kidney International. 75(2). 147–155. 48 indexed citations
13.
Haruyama, Naoki, Kosuke Masutani, Kazuhiko Tsuruya, et al.. (2006). Candida glabrata fungemia in a diabetic patient with neurogenic bladder: successful treatment with micafungin. Clinical Nephrology. 66(9). 214–217. 10 indexed citations
14.
Suzuki, Hidekazu, Michio Sata, Eiji Sasaki, et al.. (1986). [A case of chronic hepatitis type B with Crohn's disease].. PubMed. 83(7). 1387–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026